InstrumentGracefield NMR Facility

Ferrier Research Institute
Victoria University of Wellington
Gracefield Research Centre
69 Gracefield Road
Lower Hutt
Wellington
5010
New Zealand

EXPERTS

  • User
    • Associate Professor
    • Ferrier Research Institute
    • Associate ProfessorFerrier Research Institute
    Assoc. Prof. Simon Hinkley leads the polysaccharide research group at the Ferrier Institute and is the Director of the Master Programme in Drug Discovery and Development.

    The team has expertise in the isolation, characterization and modification of complex polysaccharides – molecules that are an intrinsic component of our diet, biochemistry and even in use as industrial and construction materials. The team currently focuses on the role these diverse molecules have in human health, the application of these complex molecules to direct tissue repair as a human therapeutic, and their modification to make new biopolymers suitable for use as commodity chemicals.

    A 15-year collaboration with the Singaporean research institute A*Star has led to lead compounds derived from the carbohydrate biopolymer Heparin. This collaborating group has moved to The University of Queensland where the team is generating new drug leads through modification of the natural product as well as de novo synthesis of drug leads. These new molecules are being developed to aid the regeneration of bone, skin and cartilage tissues.

    Simon has a background in natural products chemistry. In collaboration with Assoc. Prof. Janet Pitman a project is focusing on the rimu-fruit diet of the Kākāpō and what role this has in this charismatic and critically endangered birds breeding success and survival. Another research project focused on fungal toxins utilizes the expertise of colleague Assoc. Prof. Joanne Harvey where they are tackling what role black-molds have on respiratory disease.

    The research undertaken in the polysaccharide group is diverse: from drug discovery, characterization of terrestrial and marine carbohydrates, natural products chemistry and formulation research all utilizing analytical and organic synthetic chemistries.

    Simon has a PhD in organic chemistry from the University of Otago, which he followed with a postdoctoral role at the University of Maryland at College Park. He then spent seven years in biotech at IRL-BioPharm before joining the Ferrier team.
    Assoc. Prof. Simon Hinkley leads the polysaccharide research group at the Ferrier Institute and is the Director of the Master Programme in Drug Discovery and Development.

    The team has expertise in the isolation, characterization and modification of complex polysaccharides – molecules that are an intrinsic component of our diet, biochemistry and even in use as industrial and construction materials. The team currently focuses on the role these diverse molecules have in human health, the application of these complex molecules to direct tissue repair as a human therapeutic, and their modification to make new biopolymers suitable for use as commodity chemicals.

    A 15-year collaboration with the Singaporean research institute A*Star has led to lead compounds derived from the carbohydrate biopolymer Heparin. This collaborating group has moved to The University of Queensland where the team is generating new drug leads through modification of the natural product as well as de novo synthesis of drug leads. These new molecules are being developed to aid the regeneration of bone, skin and cartilage tissues.

    Simon has a background in natural products chemistry. In collaboration with Assoc. Prof. Janet Pitman a project is focusing on the rimu-fruit diet of the Kākāpō and what role this has in this charismatic and critically endangered birds breeding success and survival. Another research project focused on fungal toxins utilizes the expertise of colleague Assoc. Prof. Joanne Harvey where they are tackling what role black-molds have on respiratory disease.

    The research undertaken in the polysaccharide group is diverse: from drug discovery, characterization of terrestrial and marine carbohydrates, natural products chemistry and formulation research all utilizing analytical and organic synthetic chemistries.

    Simon has a PhD in organic chemistry from the University of Otago, which he followed with a postdoctoral role at the University of Maryland at College Park. He then spent seven years in biotech at IRL-BioPharm before joining the Ferrier team.
    • Masters Research or PhD student supervision
    • Industry Projects
    • Technical support
    Fields of Research
    • Natural products and bioactive compounds
    • Analytical chemistry
    • Organic chemistry
    • Industrial biotechnology
  • Manager
    • Deputy Director Commercial Research
    • Ferrier Research Institute
    • Deputy Director Commercial ResearchFerrier Research Institute

    Dr Phill Rendle has an interest in the diagnosis and treatment of rare disorders through a molecular understanding of the cause of these conditions along with providing a synthetic chemistry resource to the design of radiopharmaceuticals.

     

    He is also responsible for managing the client relationships for the Ferrier Research Institute’s fee-for-service contract research activity. “Communication is a really important part of this job. All clients are different and have different approaches and needs. I make sure we are providing solutions that is targeted to each client’s requirements.”

    Contract chemical manufacture often begins with refining the synthetic route. If larger amounts are then required for clinical trials, the synthesis can progress to GlycoSyn’s process development team and then cGMP facility on-site to manufacture material of the required quality requirements. 
    “I work very closely with GlycoSyn so it’s a seamless transition for clients. We transfer all we know about the chemistry, making the process as efficient as possible.”

    Problem-solving is an important part of Phill’s role. “It’s inevitable that things sometimes don’t go as planned with the chemistry, but we can nearly always find a way around the hurdle. Because we are totally open with our clients, they are kept fully up to date with what’s going on, so there are no surprises which is really appreciated.”

    Phill studied for his PhD at the University of Canterbury with post-docs at Durham and Oxford Universities in the UK then worked at Industrial Research Ltd before joining Victoria University of Wellington in 2014.

    Outside work, his main interest is Wellington Batucada—an energetic Brazilian-style percussion band. The group of 100 musicians and dancers play in street parades and music festivals.

    Dr Phill Rendle has an interest in the diagnosis and treatment of rare disorders through a molecular understanding of the cause of these conditions along with providing a synthetic chemistry resource to the design of radiopharmaceuticals.

     

    He is also responsible for managing the client relationships for the Ferrier Research Institute’s fee-for-service contract research activity. “Communication is a really important part of this job. All clients are different and have different approaches and needs. I make sure we are providing solutions that is targeted to each client’s requirements.”

    Contract chemical manufacture often begins with refining the synthetic route. If larger amounts are then required for clinical trials, the synthesis can progress to GlycoSyn’s process development team and then cGMP facility on-site to manufacture material of the required quality requirements. 
    “I work very closely with GlycoSyn so it’s a seamless transition for clients. We transfer all we know about the chemistry, making the process as efficient as possible.”

    Problem-solving is an important part of Phill’s role. “It’s inevitable that things sometimes don’t go as planned with the chemistry, but we can nearly always find a way around the hurdle. Because we are totally open with our clients, they are kept fully up to date with what’s going on, so there are no surprises which is really appreciated.”

    Phill studied for his PhD at the University of Canterbury with post-docs at Durham and Oxford Universities in the UK then worked at Industrial Research Ltd before joining Victoria University of Wellington in 2014.

    Outside work, his main interest is Wellington Batucada—an energetic Brazilian-style percussion band. The group of 100 musicians and dancers play in street parades and music festivals.

    • Masters Research or PhD student supervision
    • Collaborative projects
    • Media enquiries
    Fields of Research
    • Medicinal and biomolecular chemistry
    • Organic chemistry
    • Organic chemical synthesis
    • Biologically active molecules
    • Characterisation of biological macromolecules
    • Glycoconjugates
    • Analytical spectrometry